SMSara Mantovani

Sara Mantovani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sara Mantovani has a total of 227 co-authors. Here are the top co-authors by number of shared publications:

  • Daniele Diso

    Department of Thoracic Surgery, University of Rome Sapienza , Rome, Italy

    16 shared publications
  • Federico Venuta

    Thoracic Surgery Unit, Department of General Surgery, Surgical Specialties and Anestesiology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy

    16 shared publications
  • Marco Anile

    Sapienza University of Rome: Universita degli Studi di Roma La Sapienza

    16 shared publications
  • Camilla Poggi

    Thoracic Surgery Unit, Department of General Surgery, Surgical Specialties and Anestesiology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy

    12 shared publications
  • Tiziano De Giacomo

    Thoracic Surgery Unit, Department of General Surgery, Surgical Specialties and Anestesiology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy

    12 shared publications
  • Massimiliano Bassi

    Thoracic Surgery Unit, Department of General Surgery, Surgical Specialties and Anestesiology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy

    11 shared publications

Latest Publications

  • Open Access

    The Sternocleidomastoid Muscle Reverse Pad: A “Safety Net” in Catastrophic Tracheal Surgery Situation

    by Sara Mantovani, Delia Giovanniello, Massimo O. Jaus

    Background: This paper presents the outcomes of employing the inferiorly based rotated sternocleidomastoid muscle flap in complex tracheal reconstruction/repair scenarios, focusing on the key objectives of ensuring stable airway, functional digestive tract and patient survival. Methods: A retrospective analysis was performed for patients treated at two medical centers (A.O. San Camillo Forlanini, Rome, and A.O.U. Careggi, Florence) from 2011 to 2023, in which the sternocleidomastoid muscle (SCM) flap, detached from the mastoid and basicranium, was rotated on the lower pivot directly onto the repair site and pedicled to the sternal origin to ensure the continuity of the airway. Average postoperative hospital stay, follow-up period and patient survival were analyzed. Follow-up assessments encompassed bronchoscopies and CT scans conducted at intervals of 15 and 28 days, and subsequently at 3 and 9 months. Results: A total of five patients were enrolled in this study. These cases included one patient with anterior tracheal wall lesions with abundant tissue loss, one patient with an anterior wall necrosis due to descending cervical mediastinitis and three patients with extra-long tracheoesophageal fistulas (TEFs) (greater than 4.5 cm or >30% of the total tracheal length). In the case of the direct repair of a TEF with a proximal tracheal stenosis, the sternocleidomastoid muscle was used to reconstruct the tissue deficit caused by extensive loss of substance in the left lateral side of the tracheal wall. In case of repair through exclusion of the TEF, the sternocleidomastoid muscle was interposed between the visceral sutures after exclusion of the TEF by an endomechanical device, in one case even substituting the membranous part of the tracheal wall. Our technique allows rotation on the sternal head of the sternocleidomastoid muscle with the lowest rotation radius, pedicled to the sternal origin, detached from the mastoid process and superior nuchal line, thus providing optimal vascularization from the superior thyroid artery/external carotid artery and accessory vasculature from the suprascapular artery. Patients exhibited uneventful postoperative recovery concerning airway and digestive patency. The mean postoperative hospitalization duration was 41 days. The follow-up assessments were negative for postoperative complications. Conclusions: The use of sternocleidomastoid muscle flap was proposed to ensure repair and protection of the suture margin or to constitute a portion, as a scaffold, of the wall by leveraging the muscle’s vascularization and thickness. This technique may be considered a leading component in managing complex situations in tracheal surgery.

  • Technique and Controversies of Single-Lung Transplantation

    by Federico Venuta, Camilla Poggi, Sara Mantovani, Massimiliano Bassi, Davide Amore, Jacopo Vannucci

  • Open Access

    Lung cancer infiltrating the chest wall: a narrative review

    by Sara Mantovani, Massimo Osvaldo Jaus

    Background and Objective: Primary lung cancer that invades the thoracic wall presents a clinical challenge. The treatment strategies for this presentation remain controversial and involve multidisciplinary evaluation. The aim of this study was to analyze the recently published literature and provide a summary of the indications and treatment of non-small cell lung cancer (NSCLC) invading the chest wall (CW). Methods: Publications were identified through searching the PubMed database from January 2018 to December 2022. Studies published in languages other than English were excluded. Key Contents and Findings: The most important prognostic factors are R0 surgical resection and accurate nodal staging. Patients with N0 disease are candidates for en bloc resection; patients with N1/2 NSCLC have a worse prognosis and surgical excision alone is not indicated. When performing CW resection, a 1 cm margin is generally accepted. A defect larger than 5 cm or located in critical areas must be managed with reconstruction. Many materials are available for reconstruction and the choice of material should be individualized in each patient. Induction therapy, including that of chemoradiotherapy or immunotherapy, increases the opportunity for radical resection in these patients. Conclusions: Multidisciplinary evaluation enables the formulation of an individualized treatment plan according to the specific stage of disease. Restoration of the integrity of the CW is important to protect the underlying organs and avoid alteration of ventilation.

  • Open Access

    Coaxial Drainage versus Standard Chest Tube after Pulmonary Lobectomy: A Randomized Controlled Study

    by Massimiliano Bassi, Emilia Mottola, Sara Mantovani, Davide Amore, Andreina Pagini, Daniele Diso, Jacopo Vannucci, Camilla Poggi, Tiziano De Giacomo, Erino Angelo Rendina, et al.

    Chest tubes are routinely inserted after thoracic surgery procedures in different sizes and numbers. The aim of this study is to assess the efficacy of Smart Drain Coaxial drainage compared with two standard chest tubes in patients undergoing thoracotomy for pulmonary lobectomy. Ninety-eight patients (57 males and 41 females, mean age 68.3 ± 7.4 years) with lung cancer undergoing open pulmonary lobectomy were randomized in two groups: 50 received one upper 28-Fr and one lower 32-Fr standard chest tube (ST group) and 48 received one 28-Fr Smart Drain Coaxial tube (SDC group). Hospitalization, quantity of fluid output, air leaks, radiograph findings, pain control and costs were assessed. SDC group showed shorter hospitalization (7.3 vs. 6.1 days, p = 0.02), lower pain in postoperative day-1 (p = 0.02) and a lower use of analgesic drugs (p = 0.04). Pleural effusion drainage was lower in SDC group in the first postoperative day (median 400.0 ± 200.0 mL vs. 450.0 ± 193.8 mL, p = 0.04) and as a mean of first three PODs (median 325.0 ± 137.5 mL vs. 362.5 ± 96.7 mL, p = 0.01). No difference in terms of fluid retention, residual pleural space, subcutaneous emphysema and complications after chest tubes removal was found. In conclusion, Smart Drain Coaxial chest tube seems a feasible option after thoracotomy for pulmonary lobectomy. The SDC group showed a shorter hospitalization and decreased analgesic drugs use and, thus, a reduction of costs.


  • Technique and Controversies of Single-Lung Transplantation

    by Federico Venuta, Camilla Poggi, Sara Mantovani, Massimiliano Bassi, Davide Amore, Jacopo Vannucci

  • Open Access

    Prognostic impact of spread through air spaces in lung adenocarcinoma

    by Sara Mantovani, Angelina Pernazza, Massimiliano Bassi, Davide Amore, Jacopo Vannucci, Camilla Poggi, Daniele Diso, Giulia D’aMati, Carlo Della Rocca, Erino Angelo Rendina, et al.

    Spread through air spaces (STAS) is a pattern of invasion present in some adenocarcinomas (ADC). The goal of this study was to assess the impact of STAS in patients treated with different types of surgical resections and on the clinical outcome in patients with ADC of different diameters and with different degrees of nodal involvement. A total of 109 patients were reviewed. Complete surgical resection with systematic nodal dissection was achieved in all patients. The median follow-up was 65 months (3–90 months). STAS was observed in 70 cases (64.2%); 13 patients (18.5%) had lymph node involvement (N1 and N2). Overall survival and progression-free survival were higher in patients without STAS (P = 0.042; P = 0.027). The presence of STAS in tumours ≤2 cm was a predictor of worse progression-free survival following sublobar resection compared to major resections (P = 0.011). Sublobar resection of N0 STAS-positive tumours was associated with worse long-term survival compared to a major resection (P = 0.04). Statistical analyses showed that age >70 years and recurrence were independent variables for survival; smoking pack-years >20, sublobar resection and nodal involvement were independent variables for recurrence; and smoking pack-years >20 were independent variables for a history of cancer and pleural invasion for local recurrence. STAS seems to play a role in long-term survival, particularly for patients with N0 and tumours smaller than 2 cm. Further studies are necessary to validate this hypothesis.


  • Open Access

    Left Uniportal VATS for Lung Decortication After Chemical Pleurodesis Under Spontaneous Breathing in Patient with Lymphangiomyomatosis – A Case Report.

    by Sara Mantovani, Jacopo Vannucci, Massimiliano Bassi, Emilia Mottola, Federico Venuta, Marco Anile

    Background: Pneumothorax can be the first symptom of lymphangioleiomyomatosis. Patients with lymphangioleiomyomatosis have a higher risk of recurrence of pneumothorax. Chemical pleurodesis is a viable option to treat the recurrence, but in rare cases, it is not the solution. Case Presentation: We present the case of a patient with lymphangioleiomyomatosis undergoing a talc poudrage via video-assisted thoracoscopic surgery for pneumothorax that failed to re-expand the lung. We proposed to the patient a surgical approach to debride the lung parenchyma with the patient under deep sedation with spontaneous breathing. The patient was discharged on the 5th postoperative day. The chest computed tomography scan showed complete lung re-expansion. Conclusion: We advocate that video-assisted thoracoscopic surgery in patients who are awake is a feasible surgical option that permits the restoration of physiological lung expansion in selected patients who underwent chemical pleurodesis and minimizes the risk of one-lung ventilation.


  • Open Access

    Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study

    by Francesco Guerrera, Pierre Emmanuel Falcoz, Bernhard Moser, Dirk van Raemdonck, Andrea Bille’, Alper Toker, Lorenzo Spaggiari, Luca Ampollini, Claudia Filippini, Pascal Alexandre Thomas, et al.

    : OBJECTIVES: Resection of thymic tumours including the removal of both the tumour and the thymus gland (thymothymectomy; TT) is the procedure of choice and is recommended in most relevant articles in the literature. Nevertheless, in recent years, some authors have suggested that resection of the tumour (simple thymomectomy; ST) may suffice from an oncological standpoint in patients with early-stage thymoma who do not have myasthenia gravis (MG) (non-MG). The goal of our study was to compare the short- and long-term outcomes of ST versus TT in non-MG early-stage thymomas using the European Society of Thoracic Surgeons thymic database.METHODS: A total of 498 non-MG patients with pathological stage I thymoma were included in the study. TT was performed in 466 (93.6%) of 498 patients who had surgery with curative intent; ST was done in 32 (6.4%). The completeness of resection, the rate of complications, the 30-day mortality, the overall recurrence and the freedom from recurrence were compared. We performed crude and propensity score-adjusted comparisons by surgical approach (ST vs TT).RESULTS: TT showed the same rate of postoperative complications, 30-day mortality and postoperative length of stay as ST. The 5-year overall survival rate was 89% in the TT group and 55% in the ST group. The 5-year freedom from recurrence was 96% in the TT group and 79% in the ST group.CONCLUSION: Patients with early-stage thymoma without MG who have a TT show significantly better freedom from recurrence than those who have an ST, without an increase in postoperative morbidity rate.


  • Open Access

    Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease

    by Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio M. Mastroianni, Giammarco Raponi, Massimiliano Bassi, Giancarlo Ceccarelli, Massimo Mancone, Guido Antonelli, et al.


  • Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation

    by Davide Amore, Ylenia Pecoraro, Carolina Carillo, Gianluca Russo, Camilla Poggi, Marco Anile, Andreina Pagini, Massimiliano Bassi, Sara Cagnetti, Emilia Mottola, et al.